Barclays PLC Elanco Animal Health Inc Call Options Transaction History

Barclays PLC

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 15, 2024	BUY	$11.85 - $15.47 $3.08 Million - $4.02 Million	260,000 New	260,000 $3.82 Million
Q4 2023 Feb 15, 2024	BUY	$8.6 - $14.94 $258,000 - $448,200	30,000 New	30,000 $447,000
Q3 2020 Nov 12, 2020	SELL	$21.1 - $29.13 $198,340 - $273,822	-9,400 Reduced 97.92%	200 $6,000
Q2 2020 Aug 12, 2020	SELL	$18.94 - $24.93 $4.22 Million - $5.56 Million	-223,000 Reduced 95.87%	9,600 $206,000
Q1 2020 May 13, 2020	BUY	$16.68 - $32.25 $2.82 Million - $5.45 Million	169,100 Added 266.3%	232,600 $5.21 Million
Q4 2019 Feb 10, 2020	SELL	$25.29 - $29.45 $80,928 - $94,240	-3,200 Reduced 4.8%	63,500 $1.87 Million
Q3 2019 Nov 14, 2019	BUY	$25.62 - $34.96 $1.29 Million - $1.75 Million	50,200 Added 304.24%	66,700 $1.77 Million
Q2 2019 Aug 14, 2019	BUY	$31.11 - $34.79 $510,204 - $570,556	16,400 Added 16400.0%	16,500 $558,000
Q1 2019 May 15, 2019	SELL	$29.0 - $32.83 $121,800 - $137,886	-4,200 Reduced 97.67%	100 $3,000
Q4 2018 Feb 14, 2019	BUY	$29.63 - $34.5 $127,409 - $148,350	4,300 New	4,300 $136,000

438

473M

4.62M

753K

Ticker ELAN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 474,113,984
Market Cap $5.59B
Description
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.